Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NCT03442504 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DIAGNOSTIC_TEST: FES PET/CT

Sponsor

Institut Cancerologie de l'Ouest